The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
i mean i you know having the data you know that's huge so you know it's one thing to say okay access is important the other thing i would say now we have a lot of data and i'm you know i think getting the word out but more importantly showing the data what we're seeing why we think it's happening uh definitely adds some motivation
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and i think those sort of testimonials i mean again it gets back to the communities and stuff having other people talking about what they're doing is so helpful you know so it's certainly not just from us it's from again their own support groups and stuff like that it i think is extremely helpful to get people motivated
talking about like the way this disease will progress like five ten years from now yeah like potentially like that should be motivating enough and good like this isn't gonna do that like it's gonna help with your symptoms and stuff but like that's a big deal